FDA authority over tobacco regulation would be prohibited by Sen. Ford's S 1262, Rep. Payne's HR 2238.
Executive Summary
FDA TOBACCO REGULATION AUTHORITY WOULD BE PROHIBITED BY SENATE BILL, S 1262, while retaining some points of FDA Commissioner Kessler's tobacco regulation plan with regard to teen smoking prevention. Introduced by Sen. Ford (D-Ky.) on Sept. 20, the "Tobacco Products Control Act of 1995" states that "nothing in this act or any other act shall provide the Food & Drug Administration with any authority to regulate in any manner tobacco or tobacco products."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth